Filter
1013
Filtered Results: 1013
Text search:
pandémie
Featured
Recommendations
92
New Publications
24
Language
Document type
Guidelines
348
Studies & Reports
252
Fact sheets
86
Strategic & Response Plan
77
No document type
59
Manuals
57
Infographics
27
Brochures
26
Resource Platforms
24
Videos
20
Situation Updates
16
Training Material
15
Online Courses
6
Countries / Regions
Germany
133
Brazil
120
Latin America and the Carribbean
113
Colombia
66
Mozambique
57
Global
49
Angola
46
Argentina
37
Peru
35
Venezuela
32
Ecuador
28
Guinea-Bissau
26
Chile
24
Paraguay
21
Bolivia
21
El Salvador
18
Spain
16
West and Central Africa
12
Mexico
10
Portugal
10
Burkina Faso
9
Congo, Democratic Republic of
9
Honduras
8
Africa
7
Russia
7
Guatemala
7
Senegal
6
Benin
5
Cameroon
5
Niger
5
Haiti
5
Uruguay
5
Côte d’Ivoire / Ivory Coast
5
Nicaragua
5
Dominican Republic
4
Eastern Europe and Central Asia
4
Western and Central Europe
4
Mali
4
Ukraine
3
Congo-Brazzaville
3
Burundi
3
Italy
3
Tanzania
3
Middle East and North Africa
3
France
3
East and Southern Africa
3
Madagascar
3
Cuba
3
Switzerland
2
Ghana
2
Togo
2
Syria
2
Canada
2
Austria
2
South–East Asia Region
2
Luxembourg
2
Belgium
2
Eastern Europe
2
Djibouti
2
Namibia
2
Central African Republic
2
Chad
2
Kenya
1
Rwanda
1
Nigeria
1
Malawi
1
Morocco
1
Guinea
1
Cambodia
1
Cape Verde
1
Western Pacific Region
1
North America
1
South Africa
1
Vietnam
1
Moldova
1
Yemen
1
South Sudan
1
Indonesia
1
India
1
Authors & Publishers
Publication Years
Category
Countries
615
Public Health
34
Key Resources
26
Clinical Guidelines
21
Women & Child Health
19
Capacity Building
8
Pharmacy & Technologies
4
Toolboxes
COVID-19
626
Refugee
81
Rapid Response
31
Mental Health
25
TB
23
Planetary Health
22
Health Financing Toolbox
19
Caregiver
18
Global Health Education
17
NCDs
14
HIV
12
NTDs
8
Malaria
6
2.0 Rapid Response
6
Conflict
6
Pharmacy
4
AMR
3
Specific Hazards
2
Disability
2
Cholera
2
Ebola & Marburg
2
Social Ethics
2
Polio
2
Natural Hazards
1
Zika
1
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control and accountability of biological materials and information related to these materials and dualuse research,...
Este documento de orientação para elaboração de um plano nacional de operacionalização e vacinação (NDVP) apresenta um esquema que auxilia os países a: desenvolver e atualizar o respectivo NDVP para a introdução de vacinas contra a COVID-19; elaborar estratégias para a operacionalizaçã...
This paper was commissioned by N´weti and Wemos as part
of the project “Equitable health financing for a strong health
system in Mozambique”. Its purpose is to contribute to the
debate of the Mozambican Ministry of Health’s draft Health
Sector Financing Strategy (HSFS) 2025 – 2034
IHME’s Financing Global Health report provides an overview of health spending around the world, with a special focus on investments in health in low- and middle-income countries. The report examines how this funding for health is changing each year and forecasts how it may change in the future. Fi...
En su condición de departamento técnico de la OMS para el paludismo, al Programa Mundial sobre Malaria le corresponde una importante función de liderazgo de la respuesta mundial. Por medio de sus acciones directas y su red, tiene la capacidad de conformar el ecosistema de la respuesta al paludism...
O guia de campo apresenta os passos essenciais e dá orientações aos países sobre a adoção e utilização do c TPIg-c para o integrar no sistema de saúde existente. Baseia-se nas melhores práticas e nas lições aprendidas com as experiências de implementação piloto em oito países african...
Moçambique foi o primeiro país fora da região do Sahel a expandir com sucesso a quimioprevenção sazonal da malária (QSM). Neste documento de aprendizagem, descrevemos as lições decorrentes da aplicação em larga escala da QSM em Moçambique.
The far-reaching impacts of the COVID-19 pandemic underscore the critical need for evidence-informed, transparent and inclusive decision-making. Policy-makers have grappled with complex choices amidst uncertainty. They have constantly reassessed response measures while navigating their economic impl...
Global Animal Disease Information System - interactive Platform
Toolkit regarding Zika Virus
This handbook follows a comprehensive approach to health system strengthening at borders in order to support IHR national focal points and other national agencies in developing and implementing evidence-based action plans for IHR capacity development at ground crossings. The approach includes the mo...
This document is for public health specialists, health emergency responders, clinicians, health facility managers, health and care workers and IPC practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, dental practices, infecti...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
Action Plan for Implementation of Recommendations from the Evaluation of PAHO's Response to COVID-19
An external team evaluated PAHO’s response to COVID-19 to provide an independent assessment of the Pan American Sanitary Bureau’s (PASB) performance regarding preparedness for and response to the COVID-19 pandemic. The evaluations’ final report culminates with eight recommendations for actions...
Mpox is a zoonotic disease caused by a double-stranded DNA virus that belongs to the Orthopoxvirus genus of the Poxviridae family. The disease presents with symptoms similar to smallpox but with a lesser severity. It was first discovered in 1958 when two outbreaks of a poxlike disease occurred in co...
The Global Strategic Preparedness and Response Plan (SPRP) for mpox, covering the six-month period from September 2024 to February 2025, provides a framework for public health preparedness and response to the mpox emergency. The current draft, subject to Member State input, outlines the urgent actio...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th...
i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back pain, profound weakness or fatigue.
OR
ii. A per...
Mpox, previously known as monkeypox, is a viral illness caused by the monkeypox virus (MPXV).1
It causes a painful rash, enlarged lymph nodes, fever, headache, muscle ache, back pain and low energy or feeling sick. In most cases, the symptoms of mpox go away within a few weeks with supportive care...
